uniQure Company
Developing therapy for genetic diseases of the central nervous system (CNS) and liver
Technology:
Others
Industry:
Gene Therapy
Headquarters:
Amsterdam, The Netherlands
Founded Date:
2012
Funding Status:
IPO
Total Funding:
$274.5K
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership